Search for: "Gilead Sciences Inc." Results 161 - 180 of 182
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Feb 2013, 9:00 am by Dianne Saxe
In Chatham-Kent Wind Action Inc. v. [read post]
9 Apr 2009, 2:12 pm
Opinion below (5th Circuit) Petition for certiorari Brief in opposition Petitioner's reply brief Brief amicus curiae of former federal and state prosecutors (in support of petitioner) Docket: 08-1021 Title:  Gilead Sciences, Inc., et al., v. [read post]
23 Jun 2020, 11:30 am by David Jensen
  Just this spring, Gilead Sciences, Inc., of Foster City, Ca., bought a firm backed directly and indirectly by CIRM with $45 million. [read post]
14 Jul 2009, 6:37 am
(Editor’s Note: This post comes to us from Katrina Dewey, CEO & Publisher, Lawdragon, Inc.) [read post]
22 Dec 2014, 3:41 am
As Shalini Bengani explains in this post,TufAmerica Inc v W B Music Corp 13-cv-7847(LAK), decided by the US District Court for the Southern District of New York, is another one of those cases. [read post]
8 Apr 2019, 7:29 am by Kathy Tiemeier
Gilead Sciences, Inc., the manufacturer of both medications, made them accessible through a newly created subsidiary, Asegua Therapeutics LLC. [read post]
15 Dec 2014, 7:25 am
Last week was the busiest in the IPKat's history, with a total of 29 blogposts. [read post]
6 Dec 2007, 7:45 am
Raleigh, NC 27673 Phone: (919) 733-9250; (V/TTY); (800) 821-6922 (V/TTY/Toll Free in NC only) Fax: (919) 733-9173 Pathways to the Future, Inc. 525 Mineral Springs Drive Sylva, NC 28779 Phone: (828) 631-1167(V/TTY) Fax: (828) 631-1169 E-mail: pathways@main.nc.us State ADA Coordinator Larry Jones NC Office on the ADA 217 West Jones Street Raleigh, NC 27603-1336 Phone: (919) 715-2302 (V/TTY) E-mail: Larry.Jones@ncmail.net Web: http://www.doa.state.nc.us/doa/ada/ada.htm ASSISTIVE… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
23 Aug 2008, 1:23 am
: (Part 1 - SPICY IP), (Part 2 - SPICY IP)   Global – Copyright International Federation of the Phonographic Industry (IFPI): ‘Three strikes’ effort hit worldwide home run: (Ars Technica), How to attribute a Creative Commons licensed work: (Molly Kleinman), Chrysalis disappoints, as new artists fail to incubate: (IP finance), DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt)     Events 26 August:… [read post]
19 Apr 2022, 5:05 am by David W.S. Lieberman
The Anti-Kickback Statute prohibits offering or accepting kickbacks intended to generate health care business. [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is objecting… [read post]